Heterogeneously Hypofractionated Radiotherapy for Locally Advanced NSCLC
Conditions: Stage III Non-small-cell Lung Cancer; Stage IV Non-small Cell Lung Cancer; Radiotherapy Side Effect Intervention: Radiation: Heterogeneously Hypofractionated Radiotherapy Sponsors: Danish Lung Cancer Group; Odense University Hospital; Rigshospitalet, Denmark; Vejle Hospital; Herlev Hospital; Aarhus University Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Denmark Health | Hospitals | Non-Small Cell Lung Cancer | Research